Drugs / Lutropin alpha
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02108223 Comparator | Jan 2009 → Apr 2011 | infertility disorder | Sisli Hamidiye Etfal Training and Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lutropin alpha | “Group 2 received supplemental r-LH ( Lutropin alpha; Luveris, Merck Serono, France), 75IU/day to r-FSH (Gonal-f) treatment.” NCT02108223 ↗ |
| Modality | Protein / enzyme biologic | “recombinant luteinizing hormone” NCT02108223 ↗ |